compensated/decompensated middle stage increase or decrease in ETCO2 compensated/decompensated middle stage skin is pale, cold, and wet compensated/decompensated middle stage local cyanosis compensated/decompensated middle stage decrease in urinary output ...
Hospitalization for ADHF is linked to poor outcomes, with residual congestion at discharge significantly increasing the risk of HF readmissions and mortality. Diuretic resistance is a major contributor to inadequate decongestion during ADHF treatment. In this review, we discuss various decongestive strateg...
∗∗p <0.01 and ∗∗∗p <0.001 for AD-no ACLF vs. compensated cirrhosis; ap <0.05. bp <0.01 and cp <0.001 for AD-ACLF vs. AD-no ACLF. 1 Surrogates of ascites: paracentesis. spontaneous bacterial peritonitis. diuretic treatment or transjugular intrahepatic portosystemic shunt for ...